Case report: Giant lymph node metastases: a new opportunity for cancer radioimmunotherapy?
- PMID: 38348039
- PMCID: PMC10859527
- DOI: 10.3389/fimmu.2024.1357601
Case report: Giant lymph node metastases: a new opportunity for cancer radioimmunotherapy?
Abstract
Background: Despite the significant progress made in radiotherapy and chemotherapy for the treatment of cervical cancer, patients with lymph node metastasis still have a poor prognosis. It is widely accepted that lymph node metastasis plays a crucial role in the spread of cancer to other organs and is considered an independent factor in predicting a poor prognosis. However, recent research suggests that the importance of lymph nodes in tumor therapy needs to be reevaluated, as preserving the integrity of lymph nodes before immunotherapy can enhance treatment effectiveness.
Case presentation: In this report, we present two cases of advanced cervical cancer patients with giant metastatic lymph node lesions in the neck. These patients were effectively treated with a combination of local radiotherapy and immunotherapy after conventional chemoradiotherapy had failed. The combination therapy resulted in significant clinical improvements, with patient 1 achieving over 12 months of progression-free survival (PFS) and patient 2 maintaining sustained remission for an impressive 24 months.
Conclusions: The combination of local radiotherapy and immunotherapy shows promise as a viable treatment option for cervical cancer patients with distant lymph node metastasis, and the giant lymph node metastases may play an important role in this process, which might provide a new opportunity for cancer radioimmunotherapy.
Keywords: case report; cervical cancer; immunotherapy; lymph node metastasis; radiotherapy.
Copyright © 2024 Bian, Zhang, Deng, Wen and Li.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


Similar articles
-
Strategies for the Treatment of Cervical Cancer with Bulky Pelvic Lymph Nodes: An Overview of the Current Evidence.J UOEH. 2020;42(4):317-325. doi: 10.7888/juoeh.42.317. J UOEH. 2020. PMID: 33268608 Review.
-
Efficacy and safety of PD-1 inhibitor combined with concurrent chemoradiotherapy in locally advanced cervical cancer with pelvic and/or para-aortic lymph node metastases: a retrospective cohort study.Chin Clin Oncol. 2023 Aug;12(4):38. doi: 10.21037/cco-23-70. Chin Clin Oncol. 2023. PMID: 37699603
-
Extended-field radiotherapy for locally advanced cervical cancer.Cochrane Database Syst Rev. 2018 Oct 26;10(10):CD012301. doi: 10.1002/14651858.CD012301.pub2. Cochrane Database Syst Rev. 2018. PMID: 30362204 Free PMC article.
-
Comparison of salvage therapies for isolated para-aortic lymph node recurrence in patients with uterine cervical cancer after definitive treatment.Radiat Oncol. 2019 Dec 26;14(1):236. doi: 10.1186/s13014-019-1442-6. Radiat Oncol. 2019. PMID: 31878944 Free PMC article.
-
Radiation therapy for pelvic lymph node metastasis from uterine cervical cancer.Gynecol Oncol. 2013 Oct;131(1):99-102. doi: 10.1016/j.ygyno.2013.07.085. Epub 2013 Jul 19. Gynecol Oncol. 2013. PMID: 23877014
References
-
- Cibula D, Potter R, Planchamp F, Avall-Lundqvist E, Fischerova D, Haie Meder C, et al. . The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer. Radiother Oncol (2018) 127(3):404–16. doi: 10.1016/j.radonc.2018.03.003 - DOI - PubMed